Skip to main content

Peer Review reports

From: A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

Original Submission
4 Apr 2022 Submitted Original manuscript
29 May 2022 Reviewed Reviewer Report - giuseppe losurdo
13 Jun 2022 Reviewed Reviewer Report - Abdullah Ozgur Yeniova
1 Aug 2022 Author responded Author comments - Yi-Chun Chen
Resubmission - Version 2
1 Aug 2022 Submitted Manuscript version 2
26 Aug 2022 Author responded Author comments - Yi-Chun Chen
Resubmission - Version 3
26 Aug 2022 Submitted Manuscript version 3
29 Aug 2022 Author responded Author comments - Yi-Chun Chen
Resubmission - Version 4
29 Aug 2022 Submitted Manuscript version 4
2 Sep 2022 Author responded Author comments - Yi-Chun Chen
Resubmission - Version 5
2 Sep 2022 Submitted Manuscript version 5
Publishing
7 Sep 2022 Editorially accepted
12 Sep 2022 Article published 10.1186/s12876-022-02498-1

You can find further information about peer review here.

Back to article page